Kava ban broadens
This article was originally published in The Tan Sheet
Executive Summary
French health agency L'Afssaps plans to suspend sale of kava-containing products, excluding homeopathic items. In Jan. 9 statement, L'Afssaps cites 30 AEs in Germany and Switzerland, including reports that one person died and four required liver transplants, but notes it has not received AEs in France. DGCCRF, the French agency governing fraud, has spoken with two professional organizations about "suspending the utilization and deliverance" of such products, according to L'Afssaps. Last month, the UK supplement industry agreed to Medicines Control Agency's request that kava supplements be pulled from store shelves (1"The Tan Sheet" Dec. 24, 2001, p. 14)...
You may also be interested in...
Kava Removed From UK Market; FDA Contacts Healthcare Community
The UK dietary supplement industry has agreed to the Medicines Control Agency's request that marketers, suppliers and retailers of kava products pull the supplements from store shelves
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.